Immunocore Holdings (IMCR) Accumulated Expenses (2022 - 2026)
Immunocore Holdings (IMCR) reported Accumulated Expenses of $206.4 million for Q2 2026, up 43.5% from $143.79 million a year earlier but down 0.5% from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Immunocore Holdings posted Accumulated Expenses of $219.74 million, up 18.4% from FY2024.
- Accumulated Expenses has increased for three consecutive years, with a three-year compound annual growth rate of 42.0% (FY2022 to FY2025).
- By year, Accumulated Expenses came in at $185.53 million in FY2024 (+54.8%), $119.84 million in FY2023 (+56.1%) and $76.75 million in FY2022.
- Five-year quarterly Accumulated Expenses spans a low of $76.75 million in Q4 2022 and a high of $219.74 million in Q4 2025.
- Year over year, Accumulated Expenses has now increased in each of the last three quarters, with growth averaging 19.8% over the last seven quarters.
- The high point for year-over-year Accumulated Expenses in five years was Q1 2026 (growth of 75.2%); the low point was Q3 2025 (a decline of 26.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $207.39 million (Q1 2026), $219.74 million (Q4 2025) and $144.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Immunocore Holdings | 1.56 Bn | -1.92 Bn | 114.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 206.40 Mn |
| Mar 31, 2026 | 207.39 Mn |
| Dec 31, 2025 | 219.74 Mn |
| Sep 30, 2025 | 144.94 Mn |
| Jun 30, 2025 | 143.79 Mn |
| Mar 31, 2025 | 118.34 Mn |
| Dec 31, 2024 | 185.53 Mn |
| Sep 30, 2024 | 197.22 Mn |
| Jun 30, 2024 | 163.76 Mn |
| Mar 31, 2024 | 138.55 Mn |
| Dec 31, 2023 | 119.84 Mn |
| Dec 31, 2022 | 76.75 Mn |
API Access
Immunocore Holdings Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();